Market Estimates
Valuation Metrics
Financials
Trading Trends
AVTX News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Avalo Therapeutics Inc (AVTX) stock price today?
The current price of AVTX is 17.11 USD — it has increased 1 % in the last trading day.
What is Avalo Therapeutics Inc (AVTX)'s business?
Avalo Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The Company's lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. AVTX-009 is a humanized monoclonal antibody (IgG4) that binds to interleukin-1β (IL-1β) with high affinity and neutralizes its activity. IL-1β is a central driver in the inflammatory process. Overproduction or dysregulation of IL-1β is implicated in many autoimmune and inflammatory diseases. IL-1β is a major, validated target for therapeutic intervention. There is evidence that inhibition of IL-1β could be effective in hidradenitis suppurativa and a variety of inflammatory diseases in dermatology, gastroenterology, and rheumatology. AVTX-009 is in the Phase II LOTUS trial for hidradenitis suppurativa (HS).
What is the price predicton of AVTX Stock?
Wall Street analysts forecast AVTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AVTX is 37.00 USD with a low forecast of 25.00 USD and a high forecast of 48.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Avalo Therapeutics Inc (AVTX)'s revenue for the last quarter?
Avalo Therapeutics Inc revenue for the last quarter amounts to 0.00 USD, decreased -100.00 % YoY.
What is Avalo Therapeutics Inc (AVTX)'s earnings per share (EPS) for the last quarter?
Avalo Therapeutics Inc. EPS for the last quarter amounts to -2.19 USD, decreased -22.61 % YoY.
What changes have occurred in the market's expectations for Avalo Therapeutics Inc (AVTX)'s fundamentals?
How many employees does Avalo Therapeutics Inc (AVTX). have?
Avalo Therapeutics Inc (AVTX) has 23 emplpoyees as of January 09 2026.
What is Avalo Therapeutics Inc (AVTX) market cap?
Today AVTX has the market capitalization of 310.27M USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F9842ce1d8d5bacbfe2c398c28d5c956fa592be1b179834dd915de6a5330af910.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fdefault_image%2Fnewsfilter.png&w=384&q=75)